BRPI0606955A2 - pirróis substituìdos, composições que os contêm, processo de produção e utilização - Google Patents

pirróis substituìdos, composições que os contêm, processo de produção e utilização

Info

Publication number
BRPI0606955A2
BRPI0606955A2 BRPI0606955-0A BRPI0606955A BRPI0606955A2 BR PI0606955 A2 BRPI0606955 A2 BR PI0606955A2 BR PI0606955 A BRPI0606955 A BR PI0606955A BR PI0606955 A2 BRPI0606955 A2 BR PI0606955A2
Authority
BR
Brazil
Prior art keywords
compositions containing
production process
substituted pyrroles
present
pyrroles
Prior art date
Application number
BRPI0606955-0A
Other languages
English (en)
Inventor
Baptiste Ronan
Michel Tabart
Catherine Souaille
Fabrice Viviani
Eric Bacque
Jean-Philippe Lettalec
Pascal Desmazeau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35478244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0606955(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BRPI0606955A2 publication Critical patent/BRPI0606955A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PIRRóIS SUBSTITUìDOS, COMPOSIçõES QUE OS CONTêM, PROCESSO DE PRODUçãO E UTILIZAçãO. A presente invenção refere-se a Pirróis substituidos, composições que os contêm, processo de produção e utilização. A presente invenção se refere notadamente à preparação de pirróis substituidas, das composições que os contêm, ao respectivo processo de preparação e à respectiva utilização como medicamento, em particular como agentes anticancerígenos.
BRPI0606955-0A 2005-02-10 2006-02-08 pirróis substituìdos, composições que os contêm, processo de produção e utilização BRPI0606955A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0501354A FR2881742B1 (fr) 2005-02-10 2005-02-10 Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation
PCT/FR2006/000286 WO2006084996A1 (fr) 2005-02-10 2006-02-08 Pyrroles substitues compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
BRPI0606955A2 true BRPI0606955A2 (pt) 2009-07-28

Family

ID=35478244

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606955-0A BRPI0606955A2 (pt) 2005-02-10 2006-02-08 pirróis substituìdos, composições que os contêm, processo de produção e utilização

Country Status (36)

Country Link
US (1) US7592365B2 (pt)
EP (1) EP1851198B1 (pt)
JP (1) JP2008530061A (pt)
KR (1) KR20070101317A (pt)
CN (1) CN101115716A (pt)
AR (1) AR052571A1 (pt)
AT (1) ATE419234T1 (pt)
AU (1) AU2006212106A1 (pt)
BR (1) BRPI0606955A2 (pt)
CA (1) CA2596822A1 (pt)
CR (1) CR9231A (pt)
CY (1) CY1108916T1 (pt)
DE (1) DE602006004566D1 (pt)
DK (1) DK1851198T3 (pt)
DO (1) DOP2006000028A (pt)
EA (1) EA013060B1 (pt)
ES (1) ES2319926T3 (pt)
FR (1) FR2881742B1 (pt)
GT (1) GT200600048A (pt)
HR (1) HRP20090158T1 (pt)
IL (1) IL184488A0 (pt)
MA (1) MA29248B1 (pt)
MX (1) MX2007008789A (pt)
MY (1) MY142082A (pt)
NO (1) NO20074528L (pt)
PA (1) PA8661601A1 (pt)
PE (1) PE20061086A1 (pt)
PL (1) PL1851198T3 (pt)
PT (1) PT1851198E (pt)
RS (1) RS50806B (pt)
SI (1) SI1851198T1 (pt)
TN (1) TNSN07241A1 (pt)
TW (1) TW200640858A (pt)
UY (1) UY29371A1 (pt)
WO (1) WO2006084996A1 (pt)
ZA (1) ZA200706157B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation
ZA200902715B (en) 2006-10-23 2010-07-28 Lexicon Pharmaceuticals Inc Process for preparing 5-alkyl-7H-pyrrolo[2,3-d]pyrimidine-2-ols
TW201111385A (en) 2009-08-27 2011-04-01 Biocryst Pharm Inc Heterocyclic compounds as janus kinase inhibitors
US20120244141A1 (en) 2010-09-28 2012-09-27 Boehringer Ingelheim International Gmbh Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
WO2020034988A1 (zh) * 2018-08-14 2020-02-20 江苏豪森药业集团有限公司 凋亡信号调节激酶1抑制剂的盐及其晶型
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107901D0 (en) * 2001-03-29 2001-05-23 Cyclacel Ltd Anti-cancer compounds
ATE404550T1 (de) * 2001-09-21 2008-08-15 Smithkline Beecham Corp Chemische verbindungen
WO2003072541A2 (en) 2001-09-27 2003-09-04 Smithkline Beecham Corporation Chemical compounds
US20040138269A1 (en) * 2002-10-11 2004-07-15 Sugen, Inc. Substituted pyrroles as kinase inhibitors
GB0229581D0 (en) * 2002-12-19 2003-01-22 Cyclacel Ltd Use
EP1606284B1 (en) * 2003-03-13 2009-12-02 Vertex Pharmaceuticals Incorporated Compositions useful as protein kinase inhibitors
DE10354060A1 (de) 2003-11-19 2005-06-02 Merck Patent Gmbh Pyrrolderivate
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation

Also Published As

Publication number Publication date
PT1851198E (pt) 2009-03-26
CA2596822A1 (fr) 2006-08-17
PA8661601A1 (es) 2006-09-08
DK1851198T3 (da) 2009-05-04
US20080167368A1 (en) 2008-07-10
ZA200706157B (en) 2008-11-26
EA200701688A1 (ru) 2007-12-28
EP1851198B1 (fr) 2008-12-31
FR2881742A1 (fr) 2006-08-11
TW200640858A (en) 2006-12-01
TNSN07241A1 (en) 2008-11-21
MY142082A (en) 2010-08-30
KR20070101317A (ko) 2007-10-16
MA29248B1 (fr) 2008-02-01
WO2006084996A1 (fr) 2006-08-17
AR052571A1 (es) 2007-03-21
CY1108916T1 (el) 2014-07-02
SI1851198T1 (sl) 2009-06-30
PL1851198T3 (pl) 2009-06-30
MX2007008789A (es) 2007-09-11
HRP20090158T1 (hr) 2009-05-31
DOP2006000028A (es) 2006-09-15
JP2008530061A (ja) 2008-08-07
US7592365B2 (en) 2009-09-22
DE602006004566D1 (de) 2009-02-12
PE20061086A1 (es) 2006-11-30
EA013060B1 (ru) 2010-02-26
RS50806B (sr) 2010-08-31
UY29371A1 (es) 2006-10-02
CN101115716A (zh) 2008-01-30
IL184488A0 (en) 2007-10-31
ATE419234T1 (de) 2009-01-15
EP1851198A1 (fr) 2007-11-07
CR9231A (es) 2007-10-23
NO20074528L (no) 2007-10-31
GT200600048A (es) 2006-07-03
AU2006212106A1 (en) 2006-08-17
FR2881742B1 (fr) 2007-09-07
ES2319926T3 (es) 2009-05-14

Similar Documents

Publication Publication Date Title
BRPI0606504A2 (pt) pirazolo piridinas substituìdas, composições que as contêm, processo de fabricação e utilização
BRPI0911273B8 (pt) composição farmacêutica compreendendo um inibidor de dpp-iv, bem como processo para sua preparação
BR112014018378A2 (pt) comprimido para administração oral compreendendo ácido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il) ciclopropanocarbo-xamido)-3-metilpiridin-2-il)benzoico, processo contínuo para a preparação do mesmo, composição farmacêutica, kit e uso
CU20140141A7 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas
BR122020008544B8 (pt) uso de 4-aril-1,4-di-hidro-1,6-naftiridinamidas substituídas, e medicamento
ECSP099320A (es) Compuestos de tetrahidropirrolopiracina sustituida y su aplicación en medicamentos
DOP2006000057A (es) Composición farmaceútica para el tratamiento del cáncer
BRPI0710405B8 (pt) comprimido de racecadotril, processo de preparação de um comprimido de racecadotril e uso de racecadotril
BRPI0908406B8 (pt) Derivados de quinoxalinona, processo para a preparação dos mesmos, seu uso e composição farmacêutica
CR10247A (es) Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica
BR112015002464B8 (pt) processo para a preparação de carbamat-benzoxazinona, carbamat-benzoxazinona e uso da carbamat-benzoxazinona
PA8671301A1 (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización
BRPI0411001A (pt) produtos aril-heteroaromáticos, composições que os contêm e utilização
BR112012024339A2 (pt) invólucros para tampão desintegráveis e suas aplicações
BRPI0606761A2 (pt) pirróis e imidazóis substituìdos, composições que os contêm, processo de produção e utilização
BR112014027047A2 (pt) nova formulação
BRPI0718999A2 (pt) Pirazois substituídos, composições que os contêm, processo de produção e utilização
BR112015006363A2 (pt) combinações farmacêuticas compreendendo ligantes angiopoietina-2/dll4 duplos e agentes anti-vegf-r
BRPI0822066A2 (pt) derivados diolatos daizênio, o respectivo processo de preparo e as composições farmacêuticas que os contêm
BRPI0908569B8 (pt) estimuladores de secreção de insulina derivados de piridopirazinonas, seu uso, e composição farmacêutica
ECSP088472A (es) Derivados de 9-cloro-15-desoxiprostaglandina, procesos para su preparación y su uso como medicamento
BRPI0606955A2 (pt) pirróis substituìdos, composições que os contêm, processo de produção e utilização
BRPI0516663A (pt) bengamidas que possuem um ciclocaprolactama substituìdo, processo de preparo, composições que os contém e a utilização
BRPI0516666A (pt) 2-alcóxi-3,4,5-trihidróxi-alquilamidas, o respectivo preparo, composições que as contém e a respectiva utilização
MA34480B1 (fr) Docosahexanoate de panthényle et son utilisation pour traiter et prévenir les maladies cardiovasculaires

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.